回顾高钙尿症的病因。总结高钙尿症的治疗。描述高钙尿症患者的评估。解释改善跨专业团队成员之间护理协调的方式,以改善受高钙尿症影响的患者的结果。
Hypercalciuria
Stephen W. Leslie 1, Hussain Sajjad 2
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan.
2021 Sep 17.
Affiliations expand
PMID: 28846247
Bookshelf ID: NBK448183
1.
Pak CY, Sakhaee K, Moe OW, Poindexter J, Adams-Huet B, Pearle MS, Zerwekh JE, Preminger GM, Wills MR, Breslau NA, Bartter FC, Brater DC, Heller HJ, Odvina CV, Wabner CL, Fordtran JS, Oh M, Garg A, Harvey JA, Alpern RJ, Snyder WH, Peters PC. Defining hypercalciuria in nephrolithiasis. Kidney Int. 2011 Oct;80(7):777-82. [PMC free article] [PubMed]
2.
Martínez García M, Trincado Aznar P, Pérez Fernández L, Azcona Monreal I, López Alaminos ME, Acha Pérez J, Albero Gamboa R. A comparison of induced effects on urinary calcium by thiazides and different dietary salt doses: Implications in clinical practice. Nefrologia (Engl Ed). 2019 Jan - Feb;39(1):73-79. [PubMed]
3.
Quiñones-Vázquez S, Liriano-Ricabal MDR, Santana-Porbén S, Salabarría-González JR. Calcium-creatinine ratio in a morning urine sample for the estimation of hypercalciuria associated with non-glomerular hematuria observed in children and adolescents. Bol Med Hosp Infant Mex. 2018;75(1):41-48. [PubMed]
4.
Vieira MS, Francisco PC, Hallal ALLC, Penido MGMG, Bresolin NL. Association between dietary pattern and metabolic disorders in children and adolescents with urolithiasis. J Pediatr (Rio J). 2020 May - Jun;96(3):333-340. [PubMed]
5.
Downie ML, Alexander RT. Molecular mechanisms altering tubular calcium reabsorption. Pediatr Nephrol. 2021 Apr 01; [PubMed]
6.
Penniston KL, Nakada SY. Updates in the Metabolic Management of Calcium Stones. Curr Urol Rep. 2018 Apr 16;19(6):41. [PubMed]
7.
Hu H, Zhang J, Lu Y, Zhang Z, Qin B, Gao H, Wang Y, Zhu J, Wang Q, Zhu Y, Xun Y, Wang S. Association between Circulating Vitamin D Level and Urolithiasis: A Systematic Review and Meta-Analysis. Nutrients. 2017 Mar 18;9(3) [PMC free article] [PubMed]
8.
Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Ferraro M, Gambaro G, Gelosa M, Guttilla A, Illiano E, Martino M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F., CLU Working Group. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Arch Ital Urol Androl. 2015 Jul 07;87(2):105-20. [PubMed]
9.
Haberal HB, Artykov M, Hazir B, Altan M, Citamak B, Kahraman O, Tekgul S, Dogan HS. An Important Risk Factor Affecting Hypercalciuria in Children: Vesicoureteral Reflux. Eur J Pediatr Surg. 2020 Nov 22; [PubMed]
10.
Pozdzik A, Maalouf N, Letavernier E, Brocheriou I, Body JJ, Vervaet B, Van Haute C, Noels J, Gadisseur R, Castiglione V, Cotton F, Gambaro G, Daudon M, Sakhaee K. Meeting report of the "Symposium on kidney stones and mineral metabolism: calcium kidney stones in 2017". J Nephrol. 2019 Oct;32(5):681-698. [PubMed]
11.
Williams CP, Child DF, Hudson PR, Soysa LD, Davies GK, Davies MG, De Bolla AR. Inappropriate phosphate excretion in idiopathic hypercalciuria: the key to a common cause and future treatment? J Clin Pathol. 1996 Nov;49(11):881-8. [PMC free article] [PubMed]
12.
Prié D, Ravery V, Boccon-Gibod L, Friedlander G. Frequency of renal phosphate leak among patients with calcium nephrolithiasis. Kidney Int. 2001 Jul;60(1):272-6. [PubMed]
13.
Ryan LE, Ing SW. Idiopathic hypercalciuria: Can we prevent stones and protect bones? Cleve Clin J Med. 2018 Jan;85(1):47-54. [PubMed]
14.
Leslie SW, Sajjad H, Bashir K. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jun 5, 2021. 24-Hour Urine Testing for Nephrolithiasis Interpretation. [PubMed]
15.
Minisola S, Gianotti L, Bhadada S, Silverberg SJ. Classical complications of primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):791-803. [PubMed]
16.
Negri AL, Spivacow R, Del Valle E, Fradinger E, Marino A, Zanchetta JR. Renal phosphate leak in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Urol Res. 2003 Dec;31(6):378-81. [PubMed]
17.
Alon US. The Effects of Diuretics on Mineral and Bone Metabolism. Pediatr Endocrinol Rev. 2018 Mar;15(4):291-297. [PubMed]
18.
Blair B, Fabrizio M. Pharmacology for renal calculi. Expert Opin Pharmacother. 2000 Mar;1(3):435-41. [PubMed]
19.
Doizi S, Poindexter JR, Pearle MS, Blanco F, Moe OW, Sakhaee K, Maalouf NM. Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers. J Urol. 2018 Dec;200(6):1278-1284. [PMC free article] [PubMed]
20.
Ehlayel AM, Copelovitch L. Update on Dent Disease. Pediatr Clin North Am. 2019 Feb;66(1):169-178. [PubMed]
肾脏中的克洛托( a )klotho蛋白的肾脏分布。Klotho 在远曲小管 (DCT) 和连接小管 (CNT) 20 中与瞬时受体电位 Vallinoid 5 (TRPV5)、Na2+/Ca2+ 交换剂 (NCX1) 和钙结合蛋白-D28K 共表达。( b )klotho调节钙稳态的建议机制。PTH,甲状旁腺激素;FGF23,成纤维细胞生长因子。
不感兴趣
看过了
取消
人点赞
人收藏
打赏
不感兴趣
看过了
取消
您已认证成功,可享专属会员优惠,买1年送3个月!
开通会员,资料、课程、直播、报告等海量内容免费看!
打赏金额
认可我就打赏我~
1元 5元 10元 20元 50元 其它打赏作者
认可我就打赏我~
扫描二维码
立即打赏给Ta吧!
温馨提示:仅支持微信支付!
已收到您的咨询诉求 我们会尽快联系您